Global Fluoroscopy C Arms Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 2.78 Billion |
 Market Size (Forecast Year) |
USD 4.05 Billion |
 CAGR |
% |
| Major Markets Players |
|
Global Fluoroscopy - C Arms Market, By Product Type (C-Arms and Fluoroscopy Devices), Application (Image-Guided Biopsy, Angiography, and Discography), End User (Hospitals, Speciality Clinics, and Diagnostics Centers) – Industry Trends and Forecast to 2031.
Fluoroscopy - C Arms Market Analysis and Size
Global fluoroscopy - C arms market size was valued at USD 2.78 billion in 2023 and is projected to reach USD 4.05 billion by 2031, with a CAGR of 4.8% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable to 2016-2021) |
|
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product Type (C-Arms and Fluoroscopy Devices), Application (Image-Guided Biopsy, Angiography, and Discography), End User (Hospitals, Speciality Clinics, and Diagnostics Centers) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America |
|
Market Players Covered |
GENERAL ELECTRIC COMPANY (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthcare Private Limited (Germany), CANON MEDICAL SYSTEMS CORPORATION (Japan), Shimadzu Corporation (Japan), Carestream Health. (U.S.), EcoRay (South Korea), Eurocolumbus s.r.l. (Italy), GEMSS Co.,Ltd. (South Korea), Hitachi, Ltd. (Japan), Hologic, Inc. (U.S.), ITALRAY (Italy), Varex Imaging Corporation (U.S.), Whale Imaging (U.S.), Ziehm Imaging GmbH (Germany), Allengers (India), DMS Group (France), Omega Medical Imaging, LLC. (U.S.), OrthoScan, Inc (U.S.), Varian Medical Systems, Inc. (U.S.), Diagnostics (Greece), Nova Biomedical (U.S.), Sysmex Corporation (Japan) |
|
Market Opportunities |
|
Market Definition
Fluoroscopy - C Arms Market Dynamics
Drivers
- Increasing Adoption of Minimally Invasive Procedures
The trend towards minimally invasive procedures is driven by their lower risk, shorter recovery times, and reduced hospital stays. Patients and healthcare providers alike increasingly prefer these procedures. Fluoroscopy C-Arms play a crucial role in guiding these procedures, providing real-time imaging that enhances precision and safety. This increasing adoption of minimally invasive procedures is a significant driver of market growth, as the demand for fluoroscopy C-Arms continues to rise in tandem with the popularity of these procedures.
- Increasing Prevalence of Chronic Diseases
The global rise in chronic diseases, such as cardiovascular disorders and orthopedic conditions, is a key factor driving the demand for fluoroscopy C-Arms. These devices are essential in the diagnosis and treatment of such conditions, providing detailed imaging that helps healthcare professionals make accurate diagnoses and perform targeted interventions. As the prevalence of chronic diseases continues to increase, so does the need for fluoroscopy C-Arms, making this a significant driver of market growth.
Opportunities
- Focus on Patient Safety
There is a growing focus on patient safety in healthcare, particularly in procedures involving radiation exposure. Fluoroscopy procedures, which use X-rays to provide real-time imaging, carry a risk of radiation exposure for both patients and healthcare providers. As a result, there is increasing emphasis on minimizing radiation doses and ensuring the safe use of fluoroscopy equipment. This focus on patient safety is driving the adoption of fluoroscopy C-Arms, as these devices are designed to minimize radiation exposure while providing high-quality imaging, making them an attractive option for healthcare facilities looking to prioritize patient safety.
- Rising Demand for Outpatient Procedures
The healthcare landscape is shifting towards more outpatient procedures, driven by factors such as cost-effectiveness, convenience, and advances in medical technology. Many outpatient procedures require real-time imaging guidance, which is where fluoroscopy C-Arms come in. These devices enable healthcare providers to perform a wide range of procedures in outpatient settings, reducing the need for hospitalization and improving patient outcomes. The rising demand for outpatient procedures presents significant opportunities for market growth as healthcare facilities invest in fluoroscopy C-Arms to meet the growing demand for these services.
Restraints/Challenges
- High Cost of C-Arm Systems
The initial investment required for these systems can be prohibitive for healthcare facilities, particularly in developing regions with limited budgets. This high cost can limit the availability of fluoroscopy C-Arms in these regions, hindering market growth. One of the major challenges hindering the adoption of fluoroscopy C-Arm systems is their high cost, especially for the more advanced models.
- Concerns Regarding Radiation Exposure
Healthcare providers and patients alike are increasingly aware of the potential risks of radiation exposure associated with fluoroscopy procedures. This awareness can lead to hesitancy in adopting fluoroscopy C-Arms, particularly among patients who may be concerned about the long-term effects of radiation exposure. Concerns regarding radiation exposure are a major challenge for market growth.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market, contact Data Bridge Market Research for an Analyst Brief; our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In July 2022, Siemens Healthineers announced that it had obtained FDA clearance for its Artis Icono Ceiling Angiography system. This system blends design flexibility with precise positioning and intelligent workflows. The upgraded rotational capabilities and streamlined cabling of its C-arm allow for cone beam CT data acquisitions
- In July 2022, Fujifilm Healthcare Americas Corporation introduced the FDR Cross, a groundbreaking hybrid c-arm and portable x-ray solution designed for hospitals and ambulatory surgery centers (ASCs)
Fluoroscopy - C Arms Market Scope
The market is segmented on the basis of product type, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Types
- C-Arms
- Mini C-Arms
- Full Size C-Arms
- Fluoroscopy Devices
Application
- Image-Guided Biopsy
- Angiography
- Discography
End Users
- Hospitals
- Specialty Clinics
- Diagnostics Centers
Fluoroscopy - C Arms Market Regional Analysis/Insights
The market is analyzed and market size insights and trends are provided by country, product type, application, and end user as referenced above.
The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America is expected to dominate the market due to the exceptional healthcare infrastructure standards in the region. The U.S. exhibits a high frequency of diagnostic examinations, a growing elderly population, and an increasing prevalence of chronic diseases, all of which contribute to its significant market share.
Asia-Pacific is expected to witness significant growth during the forecast period due to factors such as a burgeoning population and notable advancements in healthcare infrastructure across various countries in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Fluoroscopy - C Arms Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- GENERAL ELECTRIC COMPANY (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Siemens Healthcare Private Limited (Germany)
- CANON MEDICAL SYSTEMS CORPORATION (Japan)
- Shimadzu Corporation (Japan)
- Carestream Health. (U.S.)
- EcoRay (South Korea)
- Eurocolumbus s.r.l. (Italy)
- GEMSS Co.,Ltd. (South Korea)
- Hitachi, Ltd. (Japan)
- Hologic, Inc. (U.S.)
- ITALRAY (Italy)
- Varex Imaging Corporation (U.S.)
- Whale Imaging (U.S.)
- Ziehm Imaging GmbH (Germany)
- Allengers (India)
- DMS Group (France)
- Omega Medical Imaging, LLC. (U.S.)
- OrthoScan, Inc (U.S.)
- Varian Medical Systems, Inc. (U.S.)
- Diagnostics (Greece)
- Nova Biomedical (U.S.)
- Sysmex Corporation (Japan)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
